ADCT vs GILD: Which Stock is Better?
Side-by-side comparison of ADC Therapeutics SA and Gilead Sciences Inc in 2026
ADCT
ADC Therapeutics SA
$3.52
GILD
Gilead Sciences Inc
$124.14
Key Metrics Comparison
| Metric | ADCT | GILD | Winner |
|---|---|---|---|
| Market Cap | $436.05M | $154.99B | GILD |
| P/E Ratio | N/A | 19.34 | GILD |
| EPS (TTM) | $N/A | $6.46 | GILD |
| Revenue Growth | -0.1% | 0.0% | GILD |
| Gross Margin | -57.4% | 78.7% | GILD |
Analyze ADCT
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADCT or GILD a better investment?
Comparing ADCT and GILD: ADC Therapeutics SA has a market cap of $436.05M while Gilead Sciences Inc has $154.99B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADCT and GILD?
ADCT (ADC Therapeutics SA) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADCT or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADCT or GILD?
GILD has higher revenue growth at 0.0% vs -0.1% for ADCT.
Which company is more profitable: ADCT or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.7% compared to -57.4% for ADCT.
Which is the larger company: ADCT or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $154.99B compared to $436.05M for ADCT.
Should I buy ADCT or GILD in 2026?
Both ADCT and GILD have investment merit. ADCT trades at $3.52 while GILD trades at $124.14. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADCT and GILD stock?
Key differences: Market Cap ($436.05M vs $154.99B), P/E Ratio (N/A vs 19.3x), Revenue Growth (-0.1% vs 0.0%), Gross Margin (-57.4% vs 78.7%).